Denali Therapeutics IncEigentümerstruktur
| Preis (2026-07-28) | 52W Hoch | 52W Tief |
| 24.05 USD | 27,3 USD | 12,58 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 34,313 USD | 15 | 4 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 158.709.737 | 10,66 | 7,65 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Denali Therapeutics Inc
Mitarbeiter 507
Handelsplatz NASDAQ
Ticker Symbol DNLI
IPO Datum 2017-12-08
Adresse 161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.denalitherapeutics.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Ryan J. Watts Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Dr. Alexander O. Schuth M.D., Ph.D. | Co-Founder, CFO, COO & Secretary |
| 3 | Dr. Dana Andersen | Chief Technical and Manufacturing Officer |
| 4 | Mr. Joe Lewcock Ph.D. | Chief Scientific Officer |
| 5 | Mr. Chris Walsh J.D. | General Counsel |
| 6 | Ms. Cindy Dunkle | Chief People Officer |
| 7 | Ms. Katie Peng M.B.A. | Chief Commercial Officer |
| 8 | Mr. Peter Chin M.D. | Acting Chief Medical Officer & Head of Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Baillie Gifford & Co Limited. | 0,00% | 0,00 Mio. USD |
| 4 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 5 | Temasek Holdings Ltd. | 0,00% | 0,00 Mio. USD |
| 6 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | NORGES BANK | 0,00% | 0,00 Mio. USD |
| 10 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 11 | UBS Asset Mgmt Americas Inc | 0,00% | 0,00 Mio. USD |
| 12 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 13 | Baker Bros Advisors LP | 0,00% | 0,00 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Holocene Advisors, LP | 0,00% | 0,00 Mio. USD |
| 16 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 17 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 18 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 19 | Pictet Asset Manangement SA | 0,00% | 0,00 Mio. USD |
| 20 | Capital Research Global Investors | 0,00% | 0,00 Mio. USD |